US2019192731A1PendingUtilityA1

Methods of use of biomaterial and injectable implant containing biomaterial

Assignee: CUTANEA LIFE SCIENCES INCPriority: Feb 21, 2007Filed: Feb 28, 2019Published: Jun 27, 2019
Est. expiryFeb 21, 2027(~0.6 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 29/00A61P 31/00A61L 27/58A61L 2300/406A61L 27/20A61L 2300/402A61K 45/06A61L 2300/404A61P 15/00A61K 31/197A61L 2400/06A61K 31/722A61L 2300/41A61L 2430/34A61L 27/54A61L 27/52A61P 23/00C08B 37/003A61L 2300/414
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to the use of a biomaterial for the treatment, repair and/or enhancement of bodily tissue insufficiencies of the vocal chords, muscles, ligaments, cartilage, post-operative regions, sexual organs and/or weight supporting areas of the feet as well as other conditions of the bones and joints. The biomaterial for use in the invention may comprise an injectable bioresorbable polysaccharide composition wherein the polysaccharide may be succinochitosan glutamate. This invention also relates to the use of a biomaterial comprising an injectable bioresorbable polysaccharide composition in which resorbable particles may be in suspension, the said particles comprising or consisting essentially of chitin and/or chitosan, which may be free of any additional formulation modifying agents, and a process for manufacturing the same. The invention also includes the use of various medicaments in the biomaterial formulations to enhance the treatment of the affected area of the body.

Claims

exact text as granted — not AI-modified
1 - 7 . (canceled) 
     
     
         8 . A method of treatment to fill a cavity in the human face or body comprising injecting a composition to said cavity, wherein said composition is in the form of a gel comprising an injectable bioresorbable polysaccharide, and wherein said composition further comprises resorbable particles which are in suspension in said gel, the said particles comprising chitin and/or chitosan. 
     
     
         9 . The method according to  claim 8 , wherein the injectable bioresorbable polysaccharide is chitosan, or a derivative thereof, said chitosan having a degree of deacetylation of about 30 to about 95%. 
     
     
         10 . The method according to  claim 8 , wherein the injectable bioresorbable polysaccharide is succinochitosan glutamate. 
     
     
         11 . The method according to  claim 8 , wherein the composition comprises about 0.1 to about 20% chitosan, or a derivative thereof, as the injectable bioresorbable polysaccharide. 
     
     
         12 . The method according to  claim 8 , wherein the weight percent of resorbable particles in the composition is between about 0.1% and about 10% by total weight of the composition. 
     
     
         13 . The method according to  claim 8 , wherein the resorbable particles consist essentially of chitin. 
     
     
         14 . The method according to  claim 8 , wherein the composition contains one or more medicaments selected from the group of: anesthetics, anti-inflammatories, analgesics, antimicrobials, antibiotics or growth factors. 
     
     
         15 . The method according to  claim 8 , wherein the resorbable particles consist essentially of chitosan. 
     
     
         16 . The method according to  claim 8 , wherein the resorbable particles do not contain polymethacrylic acid and/or ester derivatives thereof.

Join the waitlist — get patent alerts

Track US2019192731A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.